Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Rocket Pharmaceuticals (RCKT) Interest Coverage Ratio (2016 - 2025)

Historic Interest Coverage Ratio for Rocket Pharmaceuticals (RCKT) over the last 9 years, with Q3 2025 value amounting to 110.46.

  • Rocket Pharmaceuticals' Interest Coverage Ratio rose 2506.04% to 110.46 in Q3 2025 from the same period last year, while for Sep 2025 it was 132.46, marking a year-over-year increase of 890.16%. This contributed to the annual value of 144.86 for FY2024, which is 460.32% down from last year.
  • Rocket Pharmaceuticals' Interest Coverage Ratio amounted to 110.46 in Q3 2025, which was up 2506.04% from 150.42 recorded in Q2 2025.
  • Rocket Pharmaceuticals' Interest Coverage Ratio's 5-year high stood at 22.68 during Q1 2021, with a 5-year trough of 156.5 in Q2 2024.
  • For the 5-year period, Rocket Pharmaceuticals' Interest Coverage Ratio averaged around 124.2, with its median value being 134.64 (2023).
  • Its Interest Coverage Ratio has fluctuated over the past 5 years, first plummeted by 92835.36% in 2021, then surged by 2506.04% in 2025.
  • Quarter analysis of 5 years shows Rocket Pharmaceuticals' Interest Coverage Ratio stood at 95.75 in 2021, then crashed by 54.49% to 147.93 in 2022, then rose by 8.98% to 134.64 in 2023, then increased by 1.55% to 132.55 in 2024, then grew by 16.66% to 110.46 in 2025.
  • Its last three reported values are 110.46 in Q3 2025, 150.42 for Q2 2025, and 136.42 during Q1 2025.